NS
VRTX icon

NBC Securities’s Vertex Pharmaceuticals VRTX Stock Holding History

NBC Securities’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$122K Sell
246
-1
-0.4% -$443 0.01% 1010
2026
Q1 		$110K Buy
247
+1
+0.4% +$466 0.01% 1056
2025
Q4 		$112K Buy
246
+58
+31% +$25K 0.01% 1043
2025
Q3 		$73.6K Sell
188
-172
-48% -$71.9K 0.01% 1176
2025
Q2 		$160K Buy
360
+15
+4% +$6.91K 0.01% 906
2025
Q1 		$167K Buy
+345
New +$161K 0.01% 843
2024
Q4 		– Sell
-160
Closed -$74K – 2065
2024
Q3 		$74K Buy
160
+41
+34% +$19.7K 0.01% 1071
2024
Q2 		$55K Hold
119
– – 0.01% 1111
2024
Q1 		$49K Buy
119
+19
+19% +$8.03K ﹤0.01% 1143
2023
Q4 		$40K Buy
100
+1
+1% +$369 ﹤0.01% 1201
2023
Q3 		$34K Buy
+99
New +$34.6K ﹤0.01% 1256

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

NBC Securities's VRTX Position: Q2 2026 in Review

NBC Securities reduced its Vertex Pharmaceuticals (VRTX) stake by 0.4% in Q2 2026, selling an estimated $443 and leaving 246 shares worth $122K. The position accounts for 0.01% of the portfolio, ranked #1010.

NBC Securities first reported a position in VRTX in Q3 2023 and has held it in 11 quarters since. The position peaked at $167K in Q1 2025. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • NBC Securities held 246 shares of Vertex Pharmaceuticals worth $122K as of Q2 2026.
  • NBC Securities sold 1 Vertex Pharmaceuticals share in Q2 2026, an estimated $443.
  • Vertex Pharmaceuticals made up 0.01% of NBC Securities's portfolio in Q2 2026, its #1010 holding.
  • NBC Securities first reported a position in Vertex Pharmaceuticals in Q3 2023 and has held it in 11 quarters since.
  • NBC Securities's Vertex Pharmaceuticals position peaked at $167K in Q1 2025.
  • 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.